ORATOR II
02 Dec 2020
ORATOR II
NCT03210103
A Randomized Trial of Treatment De-Escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: Radiotherapy vs. Trans-Oral Surgery (ORATOR II)
London Regional Cancer Program
Cancer Type | Head and Neck |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | Oropharyngeal Squamous Cell Carcinoma |
Cancer Stage | All stages |
Anticipated Start Date | 2018-01-26 |
Anticipated End Date | 2028-08-15 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Surendranath Krishnan |
Recruitment Status | Recruiting |